Voluntis Collaborates With Salesforce to Introduce Full-service Platform for Digital Therapeutics Prescription & Reimbursem...
16 Décembre 2019 - 6:30PM
Business Wire
Regulatory News:
Voluntis (Euronext Paris, Ticker: VTX - ISIN: FR0004183960)
(Paris:VTX), a leader in digital therapeutics (DTx), today
announced its collaboration with Salesforce, the global leader in
CRM, to implement Voluntis Practice Solutions (VPS), its
full-service platform supporting DTx prescription and
reimbursement. Salesforce’s Health Cloud, Community Cloud, Sales
Cloud and Einstein Analytics solutions will be deployed together to
power VPS.
Healthcare professionals often need support when integrating
digital therapeutics into their daily clinical workflows, as well
as securing reimbursement for the new activities they perform to
remotely manage patients along their treatment journey. Voluntis
has introduced one of the industry’s most comprehensive suite of
services to address these needs, starting in the field of diabetes.
Through this partnership with Salesforce, Voluntis will aim to
automate these administrative tasks, making it seamless for
providers to adopt digital therapeutics in their daily practice.
Additionally, the use of AI will help identify and predict users’
behaviors, supporting timely and highly personalized interactions
that will contribute to extended patient engagement, improved
treatment outcomes and more efficient clinic management.
The initial focus of the platform, planned to go live in Q2
2020, is to support practices using Voluntis’ proprietary solutions
in the United States, and to automate the support of provider
billing and revenue cycle management activities. The platform will
integrate the most recent CPT codes established by Centers for
Medicare & Medicaid Services (CMS) to encourage the adoption of
digital technologies for chronic disease management.
The partnership is designed to enable future extensions of the
platform to third-party digital health solutions, additional
geographies, and other provider payment models, including
value-based contracting.
“We are delighted to meet the growing demands of practices with
a full-service platform built on a market-leading CRM solution,”
said Pierre Leurent, Chief Executive Officer, Voluntis. “Salesforce
products, analytics and AI represent a perfect fit as we aim to
deliver an unrivaled user experience for our solutions. We look
forward to this collaboration as we continue to scale our digital
therapeutics business.”
“Digital therapeutics is one of the fastest-growing sectors in
digital health, and this collaboration is a great illustration of
how Health Cloud can enable innovative use cases leveraging
best-in-class patient engagement technologies to improve chronic
disease management,” said Ashwini Zenooz, MD, SVP and GM for
Healthcare and Life Sciences, Salesforce. “We are excited to
partner with Voluntis and help advance its leadership in the
digital therapeutics space.”
About Voluntis
Voluntis creates digital therapeutics that empower people
suffering from chronic conditions to self-manage their treatment
every day, thus improving real-world outcomes. Combining mobile and
web apps, Voluntis’ solutions deliver personalized recommendations
to the patient and the care team so that they can, for example,
adjust treatment dosage, manage side effects or monitor symptoms.
These real-time recommendations are based on digitized clinical
algorithms. Leveraging its Theraxium technology platform, Voluntis
has designed and operates multiple digital therapeutics, especially
in diabetes and oncology. Voluntis has long-standing partnerships
with leading life science companies. Based out of Boston, Mass.,
and Paris, France, Voluntis is a founding member of the Digital
Therapeutics Alliance. For more information, please visit:
www.voluntis.com
About Salesforce
Salesforce is the global leader in Customer Relationship
Management (CRM), bringing companies closer to their customers in
the digital age. Founded in 1999, Salesforce enables companies of
every size and industry to take advantage of powerful
technologies—cloud, mobile, social, internet of things, artificial
intelligence, voice and blockchain—to create a 360° view of their
customers. For more information about Salesforce (NYSE: CRM),
visit: www.salesforce.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191216005624/en/
Voluntis U.S. Media Relations Lauren Kannry
lkannry@thorpesearl.com 202.491.1001
International Media Relations Nicolas Merigeau
voluntis@newcap.eu +33 (0)1 44 71 94 98